Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the University of Massachusetts Memorial Medical Center in Worcester, MA will begin enrolling patients into the Company's randomized, double-bling placebo-controlled phase 2 clinical trial in Amyotrophic Lateral Sclerosis .
http://ift.tt/1wqpFiH
http://ift.tt/1wqpFiH
No comments:
Post a Comment